NM_001370259.2:c.133G>C
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001370259.2(MEN1):c.133G>C(p.Glu45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E45G) has been classified as Pathogenic.
Frequency
Consequence
NM_001370259.2 missense
Scores
Clinical Significance
Conservation
Publications
- multiple endocrine neoplasia type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Ambry Genetics
- familial isolated hyperparathyroidismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pituitary gigantismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001370259.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEN1 | NM_001370259.2 | MANE Select | c.133G>C | p.Glu45Gln | missense | Exon 2 of 10 | NP_001357188.2 | ||
| MEN1 | NM_001407150.1 | c.133G>C | p.Glu45Gln | missense | Exon 2 of 11 | NP_001394079.1 | |||
| MEN1 | NM_001370251.2 | c.133G>C | p.Glu45Gln | missense | Exon 2 of 11 | NP_001357180.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MEN1 | ENST00000450708.7 | TSL:5 MANE Select | c.133G>C | p.Glu45Gln | missense | Exon 2 of 10 | ENSP00000394933.3 | ||
| MEN1 | ENST00000312049.11 | TSL:1 | c.133G>C | p.Glu45Gln | missense | Exon 2 of 10 | ENSP00000308975.6 | ||
| MEN1 | ENST00000424912.2 | TSL:1 | c.133G>C | p.Glu45Gln | missense | Exon 3 of 11 | ENSP00000388016.2 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia, type 1 Pathogenic:1
This missense change has been observed in individuals with clinical features of multiple endocrine neoplasia type 1 (PMID: 15670192, 20530095, 26224587, 29497973; Invitae). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Glu45 amino acid residue in MEN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12166655, 12746426, 17623761, 29239255). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MEN1 protein function. ClinVar contains an entry for this variant (Variation ID: 2137154). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 45 of the MEN1 protein (p.Glu45Gln).
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.E45Q pathogenic mutation (also known as c.133G>C), located in coding exon 1 of the MEN1 gene, results from a G to C substitution at nucleotide position 133. The glutamic acid at codon 45 is replaced by glutamine, an amino acid with highly similar properties. This variant was reported in individual(s) with features consistent with multiple endocrine neoplasia type 1 (MEN1) (Ellard S et al. Clin Endocrinol (Oxf), 2005 Feb;62:169-75; Occhi G et al. Eur J Endocrinol, 2010 Sep;163:369-76; Marini F et al. Endocrine, 2018 Oct;62:215-233; Ambry internal data). Note, this variant is also referred to as c.243G>C in the literature. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at